Therapeutic Potential of Pectin and Its Derivatives in Chronic Diseases.

Non-communicable diseases (NCDs) are described as a collection of chronic diseases that do not typically develop from an acute infection, have long-term health effects, and frequently require ongoing care and therapy. These diseases include heart disease, stroke, cancer, chronic lung disease, neurological diseases, osteoporosis, mental health disorders, etc. Known synthetic drugs for the treatment or prevention of NCDs become increasingly dangerous over time and pose high risks due to side effects such as hallucination, heart attack, liver failure, etc. As a result, scientists have had to look for other alternatives that are natural products and that are known to be less detrimental and contain useful bioactive compounds. The increasing understanding of the biological and pharmacological significance of carbohydrates has helped to raise awareness of their importance in living systems and medicine, given they play numerous biological roles. For example, pectin has been identified as a class of secondary metabolites found in medicinal plants that may play a significant role in the treatment and management of a variety of NCDs. Pectin is mainly made of homogalacturonan, which is a linear polymer composed primarily of D-galacturonic acid units (at least 65%) linked in a chain by α-(1,4)-glycosidic linkages. There are also modified pectins or derivatives that improve pectin's bioavailability. Pectin is found in the cell walls of higher plants (pteridophytes, angiosperms, and gymnosperms), particularly in the middle lamella of the plant material. Citrus pectin is used in various industries. This article compiles information that has been available for years about the therapeutic importance of pectin in chronic diseases, different modes of pectin extraction, the chemistry of pectin, and the potency of pectin and its derivatives.

Steroids and Fatty Acid Esters from Cyperus sexangularis Leaf and Their Antioxidant, Anti-Inflammatory and Anti-Elastase Properties.

Cyperus sexangularis (CS) is a plant in the sedges family (Cyperaceae) that grows abundantly in swampy areas. The leaf sheath of plants in the Cyperus genus are mostly used domestically for mat making, while they are implicated for skin treatment in traditional medicine. The plant was investigated for its phytochemical contents as well as its antioxidant, anti-inflammatory and anti-elastase properties. The n-hexane and dichloromethane leaf extracts were chromatographed on a silica gel column to afford compounds 1-6. The compounds were characterized by nuclear magnetic resonance spectroscopy and mass spectrometry. The inhibitory effect of each compound against 2,2-diphenyl-1-picrylhydrazyl (DPPH), nitric oxide (NO) and ferric ion radicals were determined by standard in vitro antioxidant methods. The in vitro anti-inflammatory response was measured using egg albumin denaturation (EAD) assay, while the anti-elastase activity of each compound in human keratinocyte (HaCaT) cells was also monitored. The compounds were characterized as three steroidal derivatives, stigmasterol (1), 17-(1-methyl-allyl)-hexadecahydro-cyclopenta[a]phenanthrene (2) and ß-sitosterol (3), dodecanoic acid (4) and two fatty acid esters, ethyl nonadecanoate (5) and ethyl stearate (6). Stigmasterol (1) exhibited the best biological properties, with IC50 of 38.18 ± 2.30 µg/mL against DPPH, 68.56 ± 4.03 µg/mL against NO and 303.58 ± 10.33 µAAE/mg against Fe3+. At 6.25 µg/mL, stigmasterol inhibited EAD by 50%. This activity was lower when compared to diclofenac (standard), which demonstrated 75% inhibition of the protein at the same concentration. Compounds 1, 3, 4 and 5 showed comparable anti-elastase activity with an IC50 ≥ 50 µg/mL, whereas the activity of ursolic acid (standard) was double fold with an IC50 of 24.80 ± 2.60 µg/mL when compared to each of the compounds. In conclusion, this study has identified three steroids (1-3), one fatty acid (4), and two fatty acid esters (5 and 6) in C. sexangularis leaf for the first time. The compounds showed considerable antioxidant, anti-inflammatory and anti-elastase properties. Thus, the findings may serve as a justification for the folkloric use of the plant as a local skin ingredient. It may also serve to validate the biological role of steroids and fatty acid compounds in cosmeceutical formulations.

Essential Oils and Their Compounds as Potential Anti-Influenza Agents.

Essential oils (EOs) are chemical substances, mostly produced by aromatic plants in response to stress, that have a history of medicinal use for many diseases. In the last few decades, EOs have continued to gain more attention because of their proven therapeutic applications against the flu and other infectious diseases. Influenza (flu) is an infectious zoonotic disease that affects the lungs and their associated organs. It is a public health problem with a huge health burden, causing a seasonal outbreak every year. Occasionally, it comes as a disease pandemic with unprecedentedly high hospitalization and mortality. Currently, influenza is managed by vaccination and antiviral drugs such as Amantadine, Rimantadine, Oseltamivir, Peramivir, Zanamivir, and Baloxavir. However, the adverse side effects of these drugs, the rapid and unlimited variabilities of influenza viruses, and the emerging resistance of new virus strains to the currently used vaccines and drugs have necessitated the need to obtain more effective anti-influenza agents. In this review, essential oils are discussed in terms of their chemistry, ethnomedicinal values against flu-related illnesses, biological potential as anti-influenza agents, and mechanisms of action. In addition, the structure-activity relationships of lead anti-influenza EO compounds are also examined. This is all to identify leading agents that can be optimized as drug candidates for the management of influenza. Eucalyptol, germacrone, caryophyllene derivatives, eugenol, terpin-4-ol, bisabolene derivatives, and camphecene are among the promising EO compounds identified, based on their reported anti-influenza activities and plausible molecular actions, while nanotechnology may be a new strategy to achieve the efficient delivery of these therapeutically active EOs to the active virus site.

Plant-Derived Natural Products as Lead Agents against Common Respiratory Diseases.

Never has the world been more challenged by respiratory diseases (RDs) than it has witnessed in the last few decades. This is evident in the plethora of acute and chronic respiratory conditions, ranging from asthma and chronic obstructive pulmonary disease (COPD) to multidrug-resistant tuberculosis, pneumonia, influenza, and more recently, the novel coronavirus (COVID-19) disease. Unfortunately, the emergence of drug-resistant strains of pathogens, drug toxicity and side effects are drawbacks to effective chemotherapeutic management of RDs; hence, our focus on natural sources because of their unique chemical diversities and novel therapeutic applications. This review provides a summary on some common RDs, their management strategies, and the prospect of plant-derived natural products in the search for new drugs against common respiratory diseases.

The Medicinal Natural Products of Cannabis sativa Linn.: A Review.

Cannabis sativa is known among many cultures for its medicinal potential. Its complexity contributes to the historical application of various parts of the plant in ethno-medicines and pharmacotherapy. C. sativa has been used for the treatment of rheumatism, epilepsy, asthma, skin burns, pain, the management of sexually transmitted diseases, difficulties during child labor, postpartum hemorrhage, and gastrointestinal activity. However, the use of C. sativa is still limited, and it is illegal in most countries. Thus, this review aims to highlight the biological potential of the plant parts, as well as the techniques for the extraction, isolation, and characterization of C. sativa compounds. The plant produces a unique class of terpenophenolic compounds, called cannabinoids, as well as non-cannabinoid compounds. The exhaustive profiling of bioactive compounds and the chemical characterization and analysis of C. sativa compounds, which modern research has not yet fully achieved, is needed for the consistency, standardization, and the justified application of Cannabis sativa products for therapeutic purposes. Studies on the clinical relevance and applications of cannabinoids and non-cannabinoid phenols in the prevention and treatment of life-threatening diseases is indeed significant. Furthermore, psychoactive cannabinoids, when chemically standardized and administered under medical supervision, can be the legal answer to the use of C. sativa.

Ursane-Type Triterpenes, Phenolics and Phenolic Derivatives from Globimetula braunii Leaf.

Globimetula braunii is a hemi-parasitic plant used in African ethnomedicine for the management of microbial infections, rheumatic pain and tumors amongst others. We report the isolation and characterization of eight compounds with their antioxidant and antimicrobial activities. The air-dried powdered leaf was macerated in EtOH/H20 (4:1). The extract was solvent-partitioned into n-hexane, EtOAc, n-BuOH and aqueous fractions. The fractions were screened for their antioxidant properties, using DPPH, FRAP, TAC and FIC assays. Antimicrobial analysis was performed using the micro-broth dilution method. The active EtOAc fraction was purified for its putative compounds on a repeated silica gel column chromatography monitored with TLC-bioautography. The isolated compounds were characterized using spectroscopic methods of UV, FT-IR, NMR and MS. Eight compounds (1-8) were isolated and characterized as 13,27-cycloursane (1), phyllanthone (2), globraunone (3), three phenolics: methyl 3,5-dihydroxy-4-methoxybenzoate (4), methyl 3-methyl-4-hydroxybenzoate (5) and guaiacol (6), as well as two phenol derivatives: 4-formaldehyde phenone (7) and 6-methoxy-2H-inden-5-ol (8). The study identified 4 and 6 as natural antioxidant compounds with potential as antimicrobial agents.

Ursolic Acid and Its Derivatives as Bioactive Agents.

Non-communicable diseases (NCDs) such as cancer, diabetes, and chronic respiratory and cardiovascular diseases continue to be threatening and deadly to human kind. Resistance to and side effects of known drugs for treatment further increase the threat, while at the same time leaving scientists to search for alternative sources from nature, especially from plants. Pentacyclic triterpenoids (PT) from medicinal plants have been identified as one class of secondary metabolites that could play a critical role in the treatment and management of several NCDs. One of such PT is ursolic acid (UA, 3 ß-hydroxy-urs-12-en-28-oic acid), which possesses important biological effects, including anti-inflammatory, anticancer, antidiabetic, antioxidant and antibacterial effects, but its bioavailability and solubility limits its clinical application. Mimusops caffra, Ilex paraguarieni, and Glechoma hederacea, have been reported as major sources of UA. The chemistry of UA has been studied extensively based on the literature, with modifications mostly having been made at positions C-3 (hydroxyl), C12-C13 (double bonds) and C-28 (carboxylic acid), leading to several UA derivatives (esters, amides, oxadiazole quinolone, etc.) with enhanced potency, bioavailability and water solubility. This article comprehensively reviews the information that has become available over the last decade with respect to the sources, chemistry, biological potency and clinical trials of UA and its derivatives as potential therapeutic agents, with a focus on addressing NCDs.

Stable isotopes analysis and heavy metal contamination in the rocky shore intertidal food web on the east coast of South Africa.

Using a short food web, i.e. from prey (macro-algae) to predator (limpet), this study investigated the concentrations and biomagnification of heavy metals from macro-algae (Ralfsia verrucosa, Ulva lactuca and Gelidium pristoides) to limpet (Scutellastra cochlear, S. longicosta, S. granularis and Cellana capensis) species. Samples were collected from four sites (Mbhashe; Mthatha; Hluleka; Silaka Mouth) in four seasons (winter 2019; spring 2019; summer 2020; spring 2020). In the laboratory samples were digested with the normal protocols, subsequently analysed for heavy metals using inductively coupled plasma optical emission spectrometry (ICP-OES), while δ15N and δ13C isotopes were analysed with Isotope Ratio Mass Spectrometer (IRMS). There were significant differences of heavy metals concentration between species of macro-algae and limpet, and metal concentration was species-specific. Spatio-temporal differences of (δ13C) isotope was evident, indicating a wide source of energy. Using (δ15N) as a proxy for biomagnification (BMF) of metals, As did not show any sign of biomagnification (BMF<1) among all seasons and sites. Though mercury and Ni had BMF >1, negative regression slope showed biodilution of these metals to the next trophic level. The toxic Cd, Pb, and essential metals Zn and Cu indicated possible biomagnification (BMF >1) between sites and seasons respectively. This study showed that the selected limpet species are notable accumulators of heavy metals and these contaminants have the potential to biomagnify in the next trophic level suggesting that they are possibly unfit for human consumption in these study sites.

Temporal and spatial variation of heavy metal concentration in four limpet species along the southeast coast of South Africa.

Rocky shores are experiencing heavy metal (HM) pollution as a result of anthropogenic activities. The information on the use of limpets Scutellastra spp. and Cellana sp. as bioindicators is limited. This study aimed to assess HM concentration in water samples, soft and shell tissues of four limpet species, Scutellastra granularis, S. longicosta; S. cochlear and Cellana capensis along the southeast coast of South Africa. Individual species were collected between 2019 and 2020 in four sites and four seasons during spring low tide. The physico-chemical parameters were simultaneously measured in situ with limpet species collection for correlation with HM. Concentration of Zn, As, Cd, Cu, Fe, Pb, Hg and Ni in limpet tissues were analysed using inductively coupled plasma optical emission spectrometry (ICP-OES). Data were explored using SPSS v26, GraphPad Prism v5, Primer v7 and MS-excel 2016. Temporal/spatial differences of physico-chemicals and HM in limpet tissues were evident. Heavy metal concentration was species specific e.g. Fe, Ni and were high in S. granularis, and Hg, As, Pb in C. capensis. The lower shore species S. longicosta and S. cochlear were notable accumulators of Zn and Cd. Limpet soft tissues concentrated 5-10 times magnitude of HM than shell tissues. This study provided a baseline information on the concentration of HM in marine limpets along the southeast coast of South Africa and suggest limpets as bioindicator species.

Chemical composition and antibacterial activity of essential oils from the rhizomes of cyperus papyrus L. grown in South Africa / Composición química y actividad antibacterial de los aceites esenciales de los rizomas de cyperus papurus L., crecidos en Sudafrica

Essential oils hydrodistilled from the rhizomes of Cyperus papyrus L. growing wild in two localities (KwaDlangezwa and Richard’s Bay) of uMhlathuze City, KwaZulu-Natal Province, South Africa has been studied. The major components of KwaDlangezwa oil were caryophyllene oxide (12.7 percent), cyperene (10.2 percent) and 1,8-cineole (8.4 percent). The oil of Richard’s Bay comprised mainly of caryophyllene oxide (24.4 percent), humulene epoxide II (13.2 percent), aristolene (9.1 percent) and aromadendrene epoxide II (7.3 percent). The antibacterial activity of the oils was assayed using agar-disc diffusion and broth-microdilution methods. The minimum inhibitory concentration (MIC) revealed that the oil samples inhibited the growth of Staphylococcus aureus (ATCC 3983 and ATCC 6538), with MIC of 1.25 and 0.31 mg/mL for each oil. Streptococcus faecalis (ATCC 29212; MIC of 1.25 and 0.6 mg/mL, respectively) and Escherichia coli (ATCC 4983; MIC of 1.25 mg/mL for both oils). Only the Richard Bay oil showed activity against Bacillus cereus and Bacillus pumilus with MIC of 1.25mg/mL, respectively.

Los aceites esenciales hidrodestilados de los rizomas de Cyperus papyrus L., que crecen en dos localidades (KwaDlangezwa y Bahía Richard) de la ciudad de uMhlathuze, la provincia KwaZulu-Natal, de Sudafrica han sido estudiados. Los mayores componentes del aceite de KwaDlangezwa fueron óxido de cariofileno (12,7 por ciento), cipereno (10,2 por ciento) y 1,8-cineol (8,4 por ciento). El aceite de la bahía de Richard consistió principalmente cariofileno (24,4 por ciento), epóxido II de humuleno (13,2 por ciento), aristoleno (9,1 por ciento) y epóxido II de aromandreno (7,3 por ciento). La actividad antibacterial de los aceites fueron ensayados utilizando la difusión en discos de agar y el método de microdilución en caldo. La concentración mínima inhibitoria (CMI) reveló que las muestras inhibieron el crecimiento de Staphylococcus aureus (ATCC 3983 y ATCC 6538), con una MIC de 1,25 y 0,31 mg/ml de cada aceite. Streptococcus faecalis (ATCC 29212; CMI de 1,25 y 0.6 mg/mL, respectivamente) y Escherichia coli (ATCC 4983; CMI de 1,25 mg/mL para ambos aceites). Solo el aceite de la bahía Richard mostró actividad contra Bacillus cereus y Bacillus pumilis con CMI de 1,25 mg/mL, respectivamente.